Stem cell therapy and its applications continue to expand on a daily basis. The use of your own stem cells is termed autologous. The use of someone else’s stem cells is termed allogenic. Animal studies demonstrate a significant problem when utilizing allogenic therapy: the transmission of genetic diseases.
Ueda et. al., demonstrated that is was possible to give osteoporosis to a normal young mouse by implanting them with stem cells from an old mouse with osteoporosis. This is very concerning and warrants caution when considering the use of allogenic stem cell therapy. Until we understand all the complexities of genes, injecting stem cells and their inherent genes from one patient into another is a significant risk.
Regenexx utilizes a patients own stem cells and therefore there is no risk of transmission of disease. Regenexx has demonstrated clinical successes in the treatment of lumbar disc bulges, tendon and ligament tears and healing of fractured bones.